Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Cindy O'Bryant to Lymphoma, T-Cell, Cutaneous

This is a "connection" page, showing publications Cindy O'Bryant has written about Lymphoma, T-Cell, Cutaneous.

 
Connection Strength
  
 
 
0.393
  
  1. Kim M, Thompson LA, Wenger SD, O'Bryant CL. Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphoma. Ann Pharmacother. 2012 Oct; 46(10):1340-8.
    View in: PubMed
    Score: 0.393
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)